Stress and arousability in schizophrenia

Schizophrenia Research
Thomas J DinzeoN M Docherty

Abstract

This paper examines trait arousability (TA), a temperament characteristic, in 47 stable outpatients with schizophrenia and 50 non-psychiatric controls. Self-reported levels of stress were obtained during a negative and positive memory speech task. Levels of TA, and the association of TA scores with reported stress during the speech tasks, were examined both between and within groups. In addition, TA scores were examined in relation to symptom presentation in the patient group. Patients reported higher levels of trait arousability and higher levels of stress than controls. Trait arousability scores were significantly associated with reported stress in one of the speech condition in patients, and with the severity of positive and affective symptoms. These results suggest that temperament characteristics of an individual with schizophrenia may be related to stress responsiveness and symptom presentation.

References

Jan 1, 1992·Annual Review of Psychology·D C Fowles
Nov 1, 1989·Journal of Abnormal Psychology·J VenturaJ P Hardesty
Jan 1, 1985·Schizophrenia Bulletin·N C Andreasen
Jan 1, 1985·Schizophrenia Bulletin·T J Crow
Jan 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·E C JohnstoneT J Crow
Jan 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·G W BrownT O Harris
Jan 1, 1986·Schizophrenia Bulletin·D LukoffK H Nuechterlein
Sep 1, 1973·The Journal of Nervous and Mental Disease·A M Ludwig, L H Stark
Nov 1, 1969·The American Psychologist·W Mischel
Aug 1, 1981·The British Journal of Psychiatry : the Journal of Mental Science·J Leff, C Vaughn
Jan 1, 1994·Acta Psychiatrica Scandinavica. Supplementum·K H NuechterleinG Bartzokis
Feb 1, 1994·The Journal of Nervous and Mental Disease·N M DochertyJ H Krystal
Jan 1, 1993·Schizophrenia Bulletin·D L Braff
Sep 1, 1996·The Journal of Nervous and Mental Disease·N M Docherty
May 1, 1997·Journal of Abnormal Psychology·N M Docherty, A S Hebert
Mar 23, 2001·Journal of Abnormal Psychology·N M DochertyA S Cohen
Aug 22, 2001·Psychological Medicine·J Van Os, P B Jones
Mar 1, 2002·The American Journal of Psychiatry·Inez Myin-GermeysJim van Os
Aug 29, 2003·Journal of Abnormal Psychology·Nancy M DochertyRuth E Dangelmaier

❮ Previous
Next ❯

Citations

Apr 22, 2014·Computers in Biology and Medicine·Kiwan HanJae-Jin Kim
Jul 11, 2014·The Journal of Nervous and Mental Disease·Margaret DombrowskiNancy M Docherty
Feb 5, 2008·Schizophrenia Bulletin·Nancy M DochertyJames P Seghers
Jul 16, 2008·Cognitive Neuropsychiatry·Annie St-HilaireNancy M Docherty
Jun 28, 2011·Schizophrenia Research·Alexandra SolimanAlain Dagher
Aug 22, 2009·European Psychiatry : the Journal of the Association of European Psychiatrists·F-W LungP-F Chen
Feb 3, 2009·Computers in Biology and Medicine·Kiwan HanSun I Kim
Jan 16, 2007·Clinical Psychology Review·Inez Myin-Germeys, Jim van Os
Feb 19, 2013·Prevention Science : the Official Journal of the Society for Prevention Research·Thomas J DinzeoEve M Sledjeski
May 25, 2010·Acta Psychiatrica Scandinavica·T LatasterInez Myin-Germeys
Jan 29, 2011·Early Intervention in Psychiatry·Marie-Chantal BeauchampMarc Corbière
Jul 23, 2015·Schizophrenia Research and Treatment·Annika ClamorTania M Lincoln
Oct 22, 2016·Behaviour Research and Therapy·Annika ClamorTania M Lincoln
Oct 14, 2016·Schizophrenia Research·Claudia LangeChristian G Huber
May 24, 2007·Journal of Clinical Nursing·Jo Gilmartin
May 16, 2007·The Journal of Nervous and Mental Disease·Thomas J Dinzeo, Nancy M Docherty

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.